comprehensive -WSS

comprehensive

author：comprehensive 2025-09-30 11:57:41 - browse：855

A person walks past the Palantir sign. -- health tech coverage from STAT — FABRICE COFFRINI/AFP via Getty Images

PALO ALTO, Calif. — At a bustling artificial intelligence conference in June hosted by data heavyweight Palantir, a handful of relative newcomers — hospital executives — milled among government and defense industry customers spiritedly trading new uses for the company’s automation and analytics services.

Palantir is best known for its work in government and intelligence, but early adopters of the company’s nascent health offerings, including leaders from Cleveland Clinic, Tampa General Hospital, and HCA, offered demos and gave keynotes last month explaining applications like sepsis monitoring or staff scheduling tools.

For the hospital systems, it’s an expensive bid to tailor the company’s AI technology to hospital operations — and an attempt to blunt the effects of severe staffing shortages and limited bed space amid a resurgence of in-person care.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： The problems with dementia villages

WSS

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

STAT Summit: Meghan O’Rourke on making chronic illness visible

Scientific mystery highlights the blind spots in genomics databases

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

CZI to create biohub to build anti

Roivant's CEO is a star, but biotech's black hole persists

knowledge

comprehensive

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Readout LOUD podcast: Live from the 2023 STAT Summit

Apple is now the first public company to be valued at $3 trillion

Study: Black kids more likely to die after surgery than white kids

Medical leaders decry Supreme Court decision on affirmative action

Multiple sclerosis has subtypes with different best treatments: study

Supreme Court strikes down use of affirmative action

Hundreds died while taking an arthritis drug, but nobody alerted patients

How to save PrEP access — and even expand it

Young boy dies in trial for Pfizer Duchenne gene therapy

leisure time

Covid silver lining: Unprecedented look at human immune system

Oral obesity drug from Viking Therapeutics hits key early target

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Harvard scientists, with Google, unveil the most detailed brain map ever

Cassava Sciences’ Alzheimer’s clinical trials should be halted

STAT Summit: Meghan O’Rourke on making chronic illness visible

knowledge

focus

Wikipedia

explore